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ExacerbationBackground: Numerous viral infections have triggered acute asthma exacerbations. Despite the fact that
diagnosis of M. pneumoniae infection is based on sero-prevalence studies but molecular diagnostic tech-
niques, such as PCR, have offered improvements in sensitivity, specificity and rapidity over the latest
methods.
Objectives: The aim of this molecular study is to determine the infection rates of M. pneumoniae in acute
asthma exacerbation in a group of Iraqi children from Baghdad and also to examine the correlation of the
disease with different variable characteristics and symptoms.
Methods: This study included 94 children between 2 and 13 years old; Fifty in-patient asthmatic children
and 44 non-asthmatic children as control group who were out-patients of the same hospital. Throat and
nasal swab samples were taken for DNA extraction and PCR procedures.
Results: PCR results show that 33.3% asthmatic patients were positive for M. pneumoniae while 66.7%
were negative (p < 0.001). 53.8% of M. pneumonia-positive asthmatic children were 2–5 years while
46.2% were 6–14 years old. Among asthmatic patients with positive PCR, 30.8% had positive history of
seasonal pattern (p = 0.026) and 69.2% have positive family history of atopy (p = 0.05).
Conclusions: Family history of atopy has strong association with asthma (p = 0.005), while factors such as
sex, residence, seasonal allergen, animal allergen, passive smoking, mode of delivery or consanguinity has
not been associated with asthma. M. pneumonia in a respective bulk among pediatric patients with
asthma constituted an important risk factor for asthma exacerbation presented as cough and wheezy
chest without fever or chest X-ray findings.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Respiratory infections were reported to either cause wheezing
episodes in children or to influence the onset as well as severity
of asthma through both complex and intersecting mechanisms.
Infections can also trigger atopic asthma while atopy in turn cause
wheezing during airway infections and can modify the course of
the disease [1].Mycoplasma pneumoniae (M. pneumoniae) is an exceptionally
small prokaryote, with no cell wall, insensitive to b-lactam antibi-
otics and Gram negative. It is a fastidiously growing bacterium,
requiring the presence of a variety of substances such as nucleo-
tides and sterols, for replication both in host and culture [2].
In humans, M. pneumoniae is among the most common organ-
isms to cause acute respiratory infections in either children or
adults [3]. It is also a major cause of community acquired pneumo-
nia affecting 10–40% of children and young adults with clinical
manifestations ranging from asymptomatic infection to fatal pneu-
monia or extra pulmonary diseases. However, the prevalence and
association of M. pneumoniae in asthma is still not clear, especially
in developing countries [4,5].
It is logical to believe, as others did, that infections with M.
pneumoniae could play a greater role than it is readily considered
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erbations of bronchial asthma. In addition, we think that large
numbers of infections with M. pneumoniae have been overlooked
and not treated, and often it has been misdiagnosed as viral infec-
tions. Therefore, it seems important that this prospective molecu-
lar study made an attempt to assess the incidence and role of M.
pneumoniae infection in children with acute exacerbation of bron-
chial and to make a correlation between bench and bedside such as
making connection between the result of PCR for detecting M.
pneumoniae DNA and the clinical and radiological findings.2. Patients and methods
A prospective case-control study was performed on 94 children
with age range of 2 to 13 years old. Fifty asthmatic children were
admitted to the Children Welfare Teaching Hospital and 44 non-
asthmatic children as outpatient visitors to the same hospital were
included as age-matched control group. The study period was from
July 1, 2013 to December 31, 2013.
This work has been carried out in accordance with The Code of
Ethics of The World Medical Association (Declaration of Helsinki)
for experiments in humans.
For each child, a questionnaire form was filled asking the infor-
mation about age, sex, growth parameter, number of wheezing
attacks, response to bronchodilator, exposure to allergen, family
history of asthma and atopy. Exclusion criteria of this study were
those patients with failure to thrive as well as patients having asso-
ciated diseases other than asthma. Each patient aged more than
6 years of age was sent for clinical tests such as chest X-ray,
echocardiography, and pulmonary function tests. Throat and nasal
swab samples were collected by taking stringent precaution and
using sterile methods for collecting the samples. Samples were
kept in special ready-to-use viral transport media (kept in collect-
ing container filled with ice bags) and transferred immediately to
the molecular laboratory of Clinical Communicable Diseases
Research Unit/College of Medicine/University of Baghdad, for
DNA extraction and PCR testing.
GENEKAM DNA ISOLATION KIT (Germany) was used to isolate
DNA from the swabs containing the nasopharyngeal specimens,
following manufacturer’s instructions. Then M. pneumoniae ampli-
fication kit (manufactured by GENEKAM Biotechnology/Germany)
was utilized to amplify the isolated DNA, following manufacturer’s
instructions. The cycling steps were as follows: initial denaturation
at 95 C for 9 min, followed by 40 cycles of denaturation at 94 C
for 30 s, annealing at 62 C for 30 s, and extension at 72 C for
30 s, and a final extension of 7 min at 72 C. PCR fragments were
separated on 2% agarose gel, stained with etidium bromide and
visualized under UV light with trans-illuminator apparatus. Pic-
ture was taken with a gel documentation system.
Statistical analysis: Data were analysed using SPSS (Statistical
Package for Social Science) program version 20. Chi-square was
used as a test of significance for the qualitative data; P value  0.05
was considered to be statistically significant and a P value < 0.01
was considered highly significant.3. Results
Thirty-nine asthmatic patients with a mean age of
(6.33 ± 3.608) years old were included in this study along with
forty-four non asthmatic patients as control group with mean
age of 6.05 ± 3.444 years old. No statistical difference was found
between means of age of cases and control (P value = 0.711). More
than half (51.28%) of asthmatic children are 2–5 years old while
the remaining 48.72% of asthmatic children were 6–14 years old.The study shows that asthma is more common in males (27/39)
than females (12/39) with male to female ratio were 2.2:1. No sta-
tistical significant difference as compared to control group as
shown in Table 1.
The association of family history of allergen (including history
of asthma, atopic dermatitis, and food allergy) in those asthmatic
patients had showed statistically significance (p  0.05) as com-
pared to the control group while there was no statistical signifi-
cance regarding the family history of allergic rhinitis in both
groups as shown in Table 2.
PCR results show that M. pneumoniae was positive (Fig. 1) in
13/39 (33.3%) of asthmatic patients while negative in 26/39
(66.7%) asthmatic patients and all control group (44 out of 44;
100%) showed negative PCR results as shown in Table 3.
More than half (53.8%) of asthmatic children with M. pneumo-
nia-had positive PCR results and were in the range of 2–5 years
old age group, while 46.2% of them are in the 6–14 years old age
group (Table 4). Among 13 asthmatic patients with positive PCR
for M. pneumoniae, the male (9/13) to female (4/13) ratio was
2.2:1 (p = 0.648), where 7/13 were living in urban areas and the
others have lived in rural areas (p = 0.199), 4/13 showed positive
history of seasonal pattern (p = 0.026) and 9/13 showed positive
family history of atopy (p = 0.05) (Table 5).
Table 6 shows the no of PCR-positive patients (i.e. having M.
pneumonia infections) and number of PCR-negative data in asth-
matic patients according to their signs and symptoms of pneu-
monia where from 13 asthmatic patients with positive PCR for
M. pneumoniae, 6/13(46.15%) were presented with fever
(p = 0.135), 10/13 (76.93%) have presented with cough
(p = 0.023) and 11/13 (84.62%) have presented with wheezy
chest (p = 0.006).4. Discussion
4.1. Risk factors of asthma
Asthma as a chronic inflammatory disease of airways is charac-
terized by hyper-responsiveness of airways to a multiple stimuli as
well as a reversible airway limitation producing recurrent respira-
tory symptoms which are in the form of shortness of breath, cough
and wheeze. The asthma pathogenesis seems to be the result of the
influence of a complex mixture of several known factors, such as
genetic, environmental, dietary change and occupation, recognized
as predisposition factors to asthma [6,7].
Our study has found that family history of asthma is an impor-
tant risk factor for this disease as showed up in 35.9% of asthmatic
children in comparison to control group which showed only in
18.2% (p = 0.05). This result were consistent with other studies
such as Burke in 2003 [8] Aws in 2005 [9], Nebal in 2007 [10]
and Mahdi in 2010 [11].
Family history of atopic dermatitis also correlated as statisti-
cally significant (p = 0.005) and as a risk factor for childhood
asthma where this result was detected in 41.1% as compared to
13.6% in the control group. This result is consistent with the results
obtained by Aws in 2005 [9] and Ronchetti in 2001 [12] who found
that a family history of atopy not only persisted but also strength-
ened over time. Our study did not found a significant correlation
between childhood asthma and family history of allergic rhinitis
(p = 0.26) which was 12.8% as compared to control group 20.5%,
this result is consistent with the result reported by Nebal in 2007
[10].
It is generally agreed that atopy is an important risk factor for
allergic diseases, such as asthma, rhinitis, and eczema, however
the extent to which this atopy accounts for each of these diseases
is controversial [13].
Table 1






Sex Male 27(69.2%) 26(59%) 0.233
Female 12(30.8%) 18 (41%)
Residence Rural 13(33.3%) 15(34%) 0.564
Urban 26 (66.7%) 29(66%)
Seasonal allergen Negative 17(43.6%) 25(56.8%) 0.163
Positive 22(56.4%) 19(43.2%)
Animal allergen Negative 24(61.5%) 31(70.5%) 0.266
Positive 15(38.5%) 13(29.5%)
Paternal smoking Negative 14(35.9%) 15(34.1%) 0.523
Positive 25(64.1%) 29(65.9%)
Mode of delivery NVD 25(64.1%) 30(68.2%) 0.436
CS 14(35.9%) 14(31.8%)
Consanguinity Negative 19(48.7%) 27(61.4%) 0.175
Positive 20(51.3%) 17(38.6%)
n: number of patients.
Table 2






Family history of asthma Positive 25(64.1%) 36(81.8%) 0.057
Negative 14(35.9%) 8(18.2%)
Family history of atopic dermatitis Positive 23(58.9%) 38(86.4%) 0.005
Negative 16(41.1%) 6(13.6%)
Family history of food allergy Positive 32(82.1%) 43(97.7%) 0.019
Negative 7(17.9%) 1(2.3%)
Family history of allergic rhinitis Positive 34(87.2%) 35(79.5%) 0.265
Negative 5(12.8%) 9(20.5%)
n: number of patients.
1       2        3         4       5      6      7       8       9      10    11    12 
Fig. 1. Image of 2% Agarose gel electrophoresis for the detection of the PCR-
amplicons of M. pneumoniae as seen under UV light via trans-illuminator apparatus
where all positive samples showed bands between 309 and 339 bp.: Lanes 1 and 12
are 100 bp-DNA molecular markers (ladders); lanes 2, 4, 7 and 9 show positive PCR
samples for M. pneumoniae; lanes 3, 5, 6 and 8 show negative PCR samples for M.
pneumoniae; lane10 for negative control; and lane 11 for positive control.
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depends on parental accountability for the state of health of family
members, which might result in an under-estimation of signifi-
cance of some of these risk factors. However these results clearlyTable 3
Association of M. pneumoniae and asthma.
PCR Asthmatics n (%) Con
PCR results Negative 26(
Positive 13(
Total 39(100%) 44(
n: number of patients.showed the importance of family atopy in the development of
childhood asthma and supported the idea that asthma may be
inherited to some extent.
This study showed no association between location of residence
(whether rural or urban) and the development of asthma
(p = 0.56), this result is consistent with study of Nebal in 2007
[10] and this may be due to the referee drainage area to our
hospital.
Regarding the result of seasonal allergy and the passive smok-
ing, both showed no associations between asthmatic group and
control (p = 0.16 and p = 0.52, respectively. This controversy might
be related to the accuracy of diagnosis of seasonal allergy and
whether it is based on prospective follow up of patients or retro-
spective history from parents.
While in regards to passive smoking, it is logical to think that
cigarette smoke, as irritant to the respiratory passages, is provok-
ing asthma in a genetically predisposed child but in our study
showed no association between asthmatic children and control
group and this can be explained by the very high prevalence of
active and passive smoking among different family members, but





Association between characteristics of asthmatic children and M. pneumoniae.
Variable characteristics PCR-negative n (%) PCR-positive n (%) P value
Sex Male 18 (69.23%) 9 (69.23%) 0.648
Female 8 (30.77%) 4 (30.77%)
Residence Rural 7 (26.92%) 6 (46.15%) 0.199
Urban 19 (73.08%) 7 (53.85%)
Seasonal allergen Negative 8 (30.77%) 9 (69.23%) 0.026
Positive 18 (69.23%) 4 (30.77%)
Family history of allergy Negative 16 (61.39%) 4 (30.77%) 0.05
Positive 10 (38.61%) 9 (69.23%)
n: number of patients.
Table 6
Distribution of PCR results of M. pneumonia according to the signs and symptoms of pneumonia.
Sign and symptoms PCR negative PCR positive P value
Fever Negative 20 (76.29%) 7 (53.85%) 0.135
Positive 6 (23.07%) 6 (46.15%)
Cough Negative 16 (61.54%) 3 (23.07%) 0.023
Positive 10 (38.46%) 10 (76.93%)
Wheezing Negative 16 (61.54%) 2 (15.38%) 0.006
Positive 10 (38.46%) 11 (84.62%)
CXR Normal 11 (42.3%) 4 (30.77%) 0.367
Hyper inflated 15 (57.7%) 9 (69.23%)
Table 4
Difference between the mean of age of patients with positive and Negative PCR results for M. pneumoniae.
PCR Number Mean Age (years) SD P value
PCR Results Negative 26 6.65 3.588 O.44
Positive 13 5.69 3.706
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pared to (35.9%) with negative history.
There was also no significant association between animal aller-
gen and asthma (p = 0.26), this result is consistent with the result
reported by Medjo and co-workers in 2013 [14] who showed early,
past and current pet-keeping were not significantly associated
with asthma as well as, neither having cat nor a dog during child-
hood period was associated with asthma.
Regarding consanguinity, our study found no correlation with
the development of asthma in childhood (p = 0.17) which in turn
was consistent with the study of Aws in 2005 [9], although a study
by Tarja and associates in 1998 [15] found that the presence of
asthma in successive generations was more likely caused by shared
genetic background than shared by environmental risk factors, and
this is possible because of high level of consanguineous marriage in
our community.
In regards to mode of delivery, our study found no association
between childhood asthma and mode of delivery (p = 0.43). Similar
results from Juhn et al. (2005) [16] and Maitra et al. in 2004 [17],
who found that mode of delivery was not associated with a subse-
quent risk of developing childhood asthma or wheezing episodes.
This may be due to the effect of mode of delivery on risk of devel-
oping asthma or wheezing episodes which varies over time. In
addition, this result has been inconsistent because of potential
selection as well as due to the ascertainment biases.
The present study does not show any association between the
characteristics of asthma cases and controls group in regards to
the use of paracetamol during pregnancy or early infancy
(p = 0.15), this may be explained by the fact that paracetamol is
an effective treatment for pain and fever in young children and
should be a stock item in every parent’s medicine cabinet.
In 2012, Bazaian [18] had found that intake of paracetamol dur-
ing the first year of life is associated with lower respiratory symp-toms, such as wheeze, cough and breathlessness, during the first
three years of life. This association was seen even though the
researchers accounted for the presence of lower respiratory tract
infections, including pneumonia, bronchitis and bronchiolitis.
Researchers have identified these types of infections as a potential
confounder, as they are either more common in children with
asthma or they are often treated with paracetamol. Even so, it is
difficult to establish a cause and effect link in order to be able to
categorically state that paracetamol usage during the first year of
life has increased the risk of lower respiratory symptoms.
Although the researchers agreed on diagnosed respiratory
symptoms, it is very difficult to exclude the possibility that the
infants have been given more paracetamol due to presence of
symptoms, even if an infection had not been diagnosed.
Importantly, there was no association between paracetamol
intake and asthma when the children were aged seven. There
was also no link between mothers’ use of paracetamol and lung
symptoms or asthma in their children.
Family history of food allergy shows significant associations
with childhood asthma as our results show 17.9% in asthmatic
patients compared to 2.3% in control group (p = 0.019). This result
was consistent with study of Laura in 2010[19], where children
with food allergies were 3.8 times more likely to have asthma than
those without food allergies. Food allergy has also appeared to be a
marker for severity of asthma. Seven times more likely people with
a food allergy get asthma attack.
4.2. M. pneumonia and asthma
The role of respiratory tract infections in the pathogenesis of
asthma is well established where many viruses have an attribution
in the exacerbation of asthma. Recently, the role of atypical patho-
gens such as Chlamydia pneumoniae and M. pneumonia in asthma
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been primarily recognised as a causative agent of community-
acquired pneumonia [1,4,5].
Recently M. pneumonia infection has been linked to asthma in
various ways, where an infection with this organism may precede
the onset of asthma, exacerbate asthma, or play a part in asthma
chronicity in some children and adults [20] which makes it more
difficult to control [1].
The lack of either awareness or rapid and specific diagnostic
techniques have made the growing importance of these pathogens
either ill understood or undefined. Although the existing data are
not conclusive, they are still suggestive enough to initiate the stud-
ies to evaluate their roles as possible mechanisms in the pathogen-
esis of asthma [1].
It is still not clear, the prevalence and association of M. pneumo-
niae with asthma, especially in the developing countries. To the
best of our knowledge, this is the first kind of molecular study in
Iraq. Initial studies have been conducted on M. pneumoniae by
Esposito et al. in year 2000 [21] using PCR, and found that M. pneu-
moniae appears significantly more often in children with acute epi-
sodes of wheezing than in controls, where the infection was
significantly associated with a history of recurrent wheezing. In
2009 in India, Avanish et al. [22] also reported the association of
M. pneumoniae infection with acute exacerbations of asthma.
These results are consistent with our results which have
demonstrated a statistically significant association between M.
pneumoniae and asthma (p  0.001), as the asthmatic group of chil-
dren showed (33.3%) positivity for M. pneumoniae by PCR method
as compared to none (0.0%) in the control group.
In contrast, the age, sex and location of residence in those asth-
matic group with positive PCR result have showed no association
when compared to those of negative M. pneumoniae (p = 0.44,
p = 0.64 and p = 0.19, respectively). The real problem in interpret-
ing these data is the techniques used to diagnose mycoplasma
infections. For children nasopharyngeal aspiration or nasal lavage
fluid samples have been used in PCR, and rates of positivity varies
in children with asthma or pneumonia. This rate would probably
be higher if the PCR was performed on broncho-alveolar lavage
fluid samples, but it is difficult to routinely obtain such samples
from children.
While in regards to seasonal allergy (p = 0.02) and family his-
tory of allergy (p = 0.05) both have showed significant correlations
with M. pneumoniae in asthmatic patients, 69% for seasonal allergy
and 38% for family history of allergy.
M. pneumonia shows significant correlation with cough
(p = 0.02) and wheezing chest (p = 0.006) as a presenting features
on examination while has neither significant correlation with fever
(p = 0.13) nor with chest X-ray findings (p = 0.36), this is mostly
due to asymptomatic feature of this infection in the majority of
cases.
5. Conclusions
Family history of atopy (asthma, atopic dermatitis, and food
allergy) has showed strong association with asthma, while eithersex, location of residence, seasonal allergen, animal allergen, pas-
sive smoking, mode of delivery, usage of paracetamol or consan-
guinity showed no association with asthma. M. pneumonia was
highly associated with asthma and thus could be considered
among the important risk factors for asthma exacerbation in our
asthmatic pediatric patients, however, no important correlation
between M. pneumonia infection and age, sex and location of resi-
dence has been found. Cough and wheezy chest were considered
important features of M. pneumonia, while neither fever nor chest
X-ray findings were correlated with this infection.
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